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Short Reports 
Thoracoscopic bullectomy and tetracycline pleurodesis 
for the treatment of spontaneous pneumothorax 
P. D. WATERWORTH*, P. KALLIS, E. R. TOWNSEND AND S. W. FOUNTAIN 
Thoracic Surgical Unit, Harefield Hospital, Middlesex, U.K. 
Initial experience of thoracoscopic bullectomy and tetracycline pleurodesis for the treatment of spontaneous 
pneumothorax is reported. Thirty-three out of 49 patients admitted with spontaneous pneumothorax were 
suitable for treatment with this minimally invasive method. This series demonstrates that this surgical 
management offers early discharge and return to normal activities with excellent medium-term results, despite 
the three early failures. It is felt that with increased experience in thoracoscopy and improved selection of 
patients, thoracoscopic bullectomy and pleurodesis 
spontaneous pneumothorax. 
Introduction 
Primary spontaneous pneumothorax is a relatively 
uncommon problem having an incidence of 5-10 per 
100 000 (l), but to the thoracic surgeon it represents 
a significant work load. The management of recur- 
rent pneumothorax poses the problem of balance 
between recurrence and complications. The ideal 
form of management, one which results in minimal 
inconvenience to the patient with no complications 
and no recurrence, has yet to be developed. 
Recurrent pneumothoraces can be managed con- 
servatively by observation, aspiration, insertion of an 
intercostal chest drain or by chemical pleurodesis 
through the chest drain. They can be treated surgi- 
cally by a wide range of procedures, those which are 
minimally invasive such as thoracoscopic pleurodesis 
and those which are not, such as thoracotomy, 
pleurectomy and bullous resection. 
Full pleurectomy first described by Gaensler (2), 
although having a low recurrence rate (0.43%), as 
reported by Weeden and Smith (3) has a definite 
incidence of major complications (4,5). Major com- 
plications such as death, respiratory failure requiring 
ventilation and haemorrhage requiring further thora- 
cotomy were as high as 3.7% in Weeden and Smith’s 
series. Indeed, the complications seen after pleurec- 
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will become the treatment of choice for primary 
tomy led Ferguson et al. (6) to perform bullectomy 
through a thoracotomy without pleurectomy. In their 
small series, no recurrences were observed after 3 yr 
follow-up suggesting that bullectomy is an important 
part of the procedure employed in dealing with 
recurrent pneumothoraces. 
Pleural abrasion and bullous ligation (7,8), 
although associated with fewer major complications, 
is still recognized to cause haemothorax, pleural 
effusion, fibrothorax and Horner’s syndrome. 
With the development of medical technology and 
instrumentation, minimally invasive procedures 
are now possible. Nathansen et al. (9) describe the 
technique of thoracoscopic ligation of bullae and 
pleurectomy. Olsen and Andersen (10) describe 
thoracoscopic tetracycline pleurodesis without bul- 
lectomy, and although few complications were 
observed, the recurrence rate was 6%. 
We describe a new minimally invasive technique 
which is safe, associated with few complications, has 
a low failure rate and to date has no recurrences. 
Materials and Methods 
During a I-yr period (July 1992-June 1993), 49 
patients with spontaneous pneumothoraces were 
admitted to Harefield Hospital, U.K. under the care 
of the two consultants. Of the 49 patients, 33 were 
considered suitable for thoracoscopic bullectomy and 
tetracycline pleurodesis. The remaining 16 patients 
were excluded for the following reasons. Seven 
patients were over the age of 65 years with symptoms 
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and signs of chronic obstructive airways disease, and 
so these were classified as secondary pneumothora- 
ces. These patients were frail with poor respiratory 
function and were deemed in need of an operation 
which would be quick and have a high success rate. 
These patients were treated with thoracoscopic talc 
pleurodesis. The remaining nine patients were all 
thought to be suitable for thoracoscopic tetracycline 
pleurodesis. At thoracoscopy, however, six patients 
were found to have dense adhesions and were 
converted to thoracotomy and underwent pleural 
abrasion, and three patients had large or extensive 
bullae requiring thoracotomy, resection of bullae and 
pleural abrasion. 
The average age of the patients was 30 years (range 
16-73 years, 28 male and 5 female). All patients had 
either a history of recurrent pneumothoraces or had a 
single pneumothorax which had failed to respond to 
conservative management with intercostal drainage. 
The mean number of episodes of pneumothorax was 
2 (range l-6 episodes of pneumothorax). Six of the 
33 patients (18%) had undergone a previous oper- 
ation for pneumothorax on the contralateral side. 
One patient had Marfan’s syndrome and one patient 
was asthmatic. Fifty-eight percent of the patients had 
a history of smoking cigarettes, but none of the 
patients were taking steroids or anti-inflammatory 
drugs. 
All patients were placed in the lateral position and 
a general anaesthetic was administered with a double 
lumen endotracheal tube in place. With the affected 
lung isolated, a 16 G needle on a lo-ml syringe was 
inserted into the sixth intercostal space just anterior 
to the spine of the scapula, and the presence of a 
pleural space was determined by aspiration. As a 
precaution, 100 ml of air was injected into the pleural 
space creating a sufficiently large pneumothorax to 
prevent damage to the lung on insertion of the 
cannulae. At the same site, a 10.5mm cannula was 
inserted thus allowing video-assisted thoracoscopic 
assessment of the pleural space, and the site and 
extent of bullae. 
If a space was present and free of adhesions, the 
procedure was commenced. If bullae were localized 
and less than 2 cm in diameter, a further two or three 
ports were inserted, under direct vision, thus facili- 
tating retraction and stapling of bullae. The second 
entry port was in the third or fourth intercostal space 
in the axilla and the third port in the eighth or ninth 
intercostal space in the anterior axillary line. The 
mean number of ports employed was 3 (range 24 
ports). Bullae were stapled using an endo GIA with a 
30 or 60 mm stapling device. Using compressed air 
through a Clerfs cocaine spray, a solution of 20 ml 
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Fig. 1 Frequency histogram of morphine equivalents used 
for analgesia post-operatively. 
of normal saline containing 1 g of tetracycline and 
20 ml of 1% lignocaine was sprayed under visualiz- 
ation throughout the pleural cavity. 
One 24 F chest drain was then inserted through the 
most anterior entry site and positioned apically under 
visualization. The lung was reinflated allowing maxi- 
mal area of apposition between visceral and parietal 
pleurae and the chest drains were connected immedi- 
ately to a suction apparatus exerting a negative 
pressure of 5 cm H,O. Post-operative analgesia was 
implemented on an ‘as-required’ opiate basis (Fig. l), 
and anti-inflammatory drugs were avoided. The 
mean follow up was 18.5 months. 
Results 
In 31 of the 33 patients, bullae were identified at 
thoracoscopy and all were apical in position. Twenty- 
nine patients underwent thoracoscopic apical bullec- 
tomy; in two cases the bullae were very small and 
were not resected. The mean number of staples used 
to perform the bullectomy was 2.7 (range l-6 
staples). The mean length of the procedure was 
54 min (range 30-95 min). One patient required con- 
version to thoracotomy for bleeding from the bullec- 
tomy staple line and was excluded from follow-up. 
Of the remaining 32 patients, 29 (91%) patients 
underwent a successful thoracoscopic bullectomy 
and tetracycline pleurodesis with no recurrences at 
follow-up. In three patients, the procedure failed 
(9%). One patient had a persistent airleak and under- 
went thoracotomy, apical pleurectomy and pleural 
abrasion 12 days after the original operation. This 
patient had a pneumothorax present for 1 month at 
the time of thoracoscopy. The other two patients had 
residual pneumothoraces on discharge and were both 
readmitted 1 week later with progression of the 
pneumothorax. Both of these patients underwent 
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thoracotomy and pleural abrasion with one patient 
requiring additional stapling of a ‘missed’ bulla. 
For the 32 patients in the study group, the chest 
drains were in situ for a mean of 4 days (range l-20 
days), but excluding the three failures, the mean was 
3 days (range l-10 days). The mean hospital stay, 
measured in post-operative days, was 53 (range 2-24 
days) or excluding the three failures, 3.7 days (range 
2-11 days). The mean post-operative blood loss for 
those treated successfully was 158 ml (range 
O-750 ml) compared to 458 ml for the three patients 
for whom the procedure failed. 
The mean cumulative post-operative analgesia 
requirement measured in morphine equivalents was 
19 mg (range CL 90 mg), six patients (19%) requiring 
no opiate analgesia (Fig. 1). 
Of the three patients for whom the procedure 
failed, all required further treatment within 30 days 
of their original operation. There have been no 
recurrences beyond 30 days at follow-up to date 
(mean follow up of 18.5 months). There were no 
deaths and only one patient developed both a chest 
infection and acute retention of urine requiring cath- 
eterization. This was one of the three patients who 
later required thoracotomy and pleural abrasion; he 
was also the oldest of the group (73 years). There 
were no other complications. 
Comment 
Successful thoracoscopic tetracycline pleurodesis 
is dependent upon careful patient selection. It is a 
technique better tolerated by young patients with 
primary spontaneous pneumothoraces and localized 
bullae, and not in those secondary to diseases such as 
chronic obstructive airways disease in which the 
bullae are often adherent, large and widespread (11). 
These patients also tolerate single lung ventilation 
poorly as their respiratory reserve is often low. 
Indeed, two of the three patients were significantly 
older than the average age of the study group (43 and 
73 years). The cause of failure in the 43-year-old 
patient was a ‘missed’ bulla due to more diffuse 
disease. This patient, in retrospect, fell into a different 
group. 
The third failure was a patient with a chronic 
pneumothorax which had been present for 1 month 
prior to thoracoscopy and as a result of this initial 
experience, it is now considered that this be a con- 
traindication to this type of surgery. As complete 
re-expansion of the lung is prerequisite for success 
after thoracoscopic tetracycline pleurodesis, it is sug- 
gested that a pneumothorax present for greater than 
2 weeks should not be treated with this method. 
For this procedure to be carried out safely, a 
pleural space should be either present or created at 
the time of surgery. If this is not the case or if dense 
adhesions are encountered, the thoracoscopic proce- 
dure should be abandoned and an open procedure 
employed. 
It is believed that the irritant but safe qualities of 
tetracycline when combined with stapling through 
the thoracoscope provides a safe, effective and mini- 
mally invasive technique for treating patients with 
acute primary spontaneous pneumothoraces. Tetra- 
cycline has been the sclerosing agent of choice (12,13) 
when used in this group of young patients, as it is 
sufficiently irritant but does not have the potentially 
hazardous properties of talc which is frequently used 
in the elderly (14,15). However, it is believed that if 
tetracycline is to be used successfully for pleurodesis, 
it must be dispersed over the whole of the pleural 
surface under direct visualization, and that the maxi- 
mum apposition of the pleurae be encouraged by 
suction on the drains immediately. It may well be 
that the lung in a chronic pneumothorax may not 
expand well and early enough during the maximal 
inflammatory reaction for effective pleurodesis. 
Equally important is the careful identification and 
stapling of all bullae as residual bullae can result 
in failure of this procedure. The use of anti- 
inflammatory drugs both pre- and post-operatively 
should also be avoided as maximal inflammatory 
reaction is desirable. 
The post-operative analgesic requirements of the 
patients in this study was a mean of 19 mg morphine 
or its equivalent, and indeed six patients required no 
opiates. It is believed that early mobilization of the 
patients will result in fewer post-operative complica- 
tions such as chest infections, deep vein thrombosis 
and pulmonary embolism. The use of 1% lignocaine 
instilled into the pleural cavity at the time of the 
pleurodesis is recommended, in order to reduce early 
post-operative pain (16). 
In those patients for whom the procedure was 
successful, the chest drain was in situ for a mean of 
3 days with a post-operative stay of 4 days, which 
is probably similar to those patients treated by a 
conventional thoracotomy and pleural abrasion. 
However, the patients treated successfully by 
this minimally invasive procedure returned to their 
normal activities/work, after 1 month (on average, 
Fig. 2). At follow-up, there have been no recurrences 
beyond 30 days post-operation. 
Conclusions 
Thoracoscopic bullectomy combined with tetracy- 
cline pleurodesis is believed to be a safe and effective, 
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Fig. 2 Frequency histogram of the time required to return 
to work/normal activities after operation. 
minimally invasive alternative for the treatment of 
primary spontaneous pneumothorax. It is a relatively 
painless procedure with few post-operative complica- 
tions and a rapid rehabilitation and return to work. 
There is clearly a need for a prospective, randomized, 
controlled clinical trial to rigorously test ,the efficacy 
of this procedure. As experience with thoracoscopy 
increases and the learning curve is mastered, it is 
believed that thoracoscopic bullectomy and pleurod- 
esis will become the treatment of choice for spon- 
taneous pneumothorax in the near future. Careful 
patient selection is essential in order to minimize the 
early failure rate. 
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